PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10090712

Polycyclic aromatic hydrocarbons in carcinogenesis.

D Warshawsky
View original source ↗Export metadata ↓

Abstract

A symposium on "Polycyclic Aromatic Hydrocarbons (PAHs) in Carcinogenesis" was presented at the third International Congress of Pathophysiology held in Lathi, Finland, 28 June-3 July 1998. The congress was also sponsored by the International Union of Biological Sciences and the International Society of Free Radical Research. Institutional support for the symposium included the Electric Power Research Institute, National Center for Toxicological Research, and EPA/National Health and Environmental Effects Research Laboratory and the Office of Solid Waste and Emergency Response. The symposium focused on the sources, carcinogenicity, genotoxicity, and risk assessment of individual and mixtures of PAHs that are found in solid wastes, Superfund sites, and other hazardous waste sites. Based on the occurrence of PAHs at numerous Superfund sites and the significant data gaps on the toxic potential of certain PAHs, the information developed during this symposium would be of value in assessing health risks of these chemicals at Superfund and other hazardous waste sites.

Explore related subjects

CarcinogensDNA AdductsEnvironmental ExposureEnvironmental PollutantsHumansMutagensNeoplasmsPolycyclic Aromatic HydrocarbonsRisk AssessmentConference Proceedings

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Warshawsky. 1999. Polycyclic aromatic hydrocarbons in carcinogenesis.. https://doi.org/10.1289/ehp.99107317

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Inter-rater agreement in the assessment of exposure to carcinogens in the offshore petroleum industry.

OBJECTIVES: To evaluate the reliability of an expert team assessing exposure to carcinogens in the offshore petroleum industry and to study how the information provided influenced the agreement among raters. METHODS: Eight experts individually assessed the likelihood of exposure for combinations of 17 carcinogens, 27 job categories and four time periods (1970-1979, 1980-1989, 1990-1999 and 2000-2005). Each rater assessed 1836 combinations based on summary documents on carcinogenic agents, which included descriptions of sources of exposure and products, descriptions of work processes carried out within the different job categories, and monitoring data. Inter-rater agreement was calculated using Cohen's kappa index and single and average score intraclass correlation coefficients (ICC) (ICC(2,1) and ICC(2,8), respectively). Differences in inter-rater agreement for time periods, raters, International Agency for Research on Cancer groups and the amount of information provided were consequently studied. RESULTS: Overall, 18% of the combinations were denoted as possible exposure, and 14% scored probable exposure. Stratified by the 17 carcinogenic agents, the probable exposure prevalence ranged from 3.8% for refractory ceramic fibres to 30% for crude oil. Overall mean kappa was 0.42 (ICC(2,1) = 0.62 and ICC(2,8) = 0.93). Providing limited quantitative measurement data was associated with less agreement than for equally well described carcinogens without sampling data. CONCLUSION: The overall kappa and single-score ICC indicate that the raters agree on exposure estimates well above the chance level. The levels of inter-rater agreement were higher than in other comparable studies. The average score ICC indicates reliable mean estimates and implies that sufficient raters were involved. The raters seemed to have enough documentation on which to base their estimates, but provision of limited monitoring data leads to more incongruence among raters. Having real exposure data, with the inherent variability of such data, apparently makes estimating exposure in a rigid semiquantitative manner more difficult.

Carcinogens↗
PubMed2007

Hplc/electrospray ionization mass spectrometric analysis of the heterocyclic aromatic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in human milk.

A new procedure has been developed for the extraction of 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) and other heterocyclic aromatic amines from human breast milk samples. Extracts were analyzed by high-performance liquid chromatography/electrospray ionization/tandem mass spectrometry (HPLC/ESI-MS/MS) with selective reaction monitoring detection. Tandem ESI-MS/MS detection provides much improved sensitivity and specificity, compared with those of a previous method that used selected ion monitoring. Milk samples were collected from 48 healthy volunteers, including five vegetarians. Donors completed a detailed dietary questionnaire. The concentrations of PhIP in the milk samples were low and below the limit of quantification (0.68 pg/mL) for all subjects except one, for whom a concentration of 1.0 pg PhIP/mL was measured. Our results indicate that the levels of PhIP in human milk are substantially lower than what was previously reported.

Carcinogens↗